Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Scientific Journal of Al-Azhar Medical Faculty [Girls] [The]. 2000; 21 (Supp. 1): 1471-1482
in English | IMEMR | ID: emr-55696

ABSTRACT

The aim of this study was to compare the hypotensive effect of nicardipine versus Na nitroprusside on 40 adult patients undergoing lumbar fusion. An anesthetic technique was used in all patients. A significant difference was noted between the two groups in the amount of blood loss and restoration of mean arterial blood pressure after the discontinuation of infusion. A prolonged hypotension was recorded in the nicardipine group versus nitroprusside group. A statistical significant decrease in arterial oxygenation was observed in the nitroprusside patients. Meanwhile, there was no significant difference in both groups regarding the surgical outcome


Subject(s)
Humans , Male , Female , Hypotension/chemically induced , Nicardipine , Nitroprusside
2.
Scientific Journal of Al-Azhar Medical Faculty [Girls] [The]. 1999; 20 (Supp. 2): 1403-1412
in English | IMEMR | ID: emr-52732

ABSTRACT

Remifentanil is a new potent opioid analgesic. This study was to determine the placental transfer of remifentanil and its effects on mother and neonate when given as an intravenous [IV] adjunct to epidural anaesthesia for cesarean section [C.S]. 20 pregnant women 37-40 weeks, underwent non emergent C.S. with epidural anaesthesia received 0.1 or 1.0 micro g/kg / minute remifentanil IV, which was continued until skin closure Maternal arterial [MA], umbilical arterial [UA] and umbilical venous [UV] blood samples were obtained immediately after delivery to evaluate the blood gases and concentrations of remifentanil. Maternal blood pressure [B.P], heart rate [HR] and respiratory rate [RR] were monitored. The results of blood gases analysis showed slight increase of MA. Partial carbon dioxide tension [PaCo2], UAPaCo2, and UVPaCo2 in both doses of remifentanil treatment. This study also showed a significant degree of placental transfer of remifentanil detected by determination of remifentanil concentration in maternal and neonatal blood samples and we found that the foetal remifentanil concentration was about 1/4 of the maternal concentration but there were no-adverse effects on the neonates [Apgar score > 7]. This was referred to its rapid metabolism and short duration of action. The present study also showed significant decrease of maternal blood pressure, heart rate and respiratory rate. Also, the sedation score was < 4 in all cases


Subject(s)
Humans , Female , Maternal-Fetal Exchange/drug effects , Cesarean Section , Chromatography, Gas , Mass Spectrometry , Infant, Newborn
SELECTION OF CITATIONS
SEARCH DETAIL